<DOC>
	<DOCNO>NCT03081208</DOCNO>
	<brief_summary>The primary objective study confirm efficacy single oral 900mg dose nolasiban increase ongoing clinical pregnancy rate 10 week post embryo transfer ( ET ) day .</brief_summary>
	<brief_title>Phase 3 Placebo Controlled Study Nolasiban Improve Pregnancy Rates Women Undergoing IVF/ICSI</brief_title>
	<detailed_description>The study prospective , randomize , parallel group , double-blind , placebo-controlled study confirm efficacy safety oxytocin receptor antagonist , nolasiban , 760 woman undergo fresh embryo transfer follow vitro fertilisation ( IVF ) intra-cytoplasmic sperm injection ( ICSI ) .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<criteria>Key Indicated IVF/ICSI context assist reproductive technology ( ART ) Follow gonadotropin release hormone ( GnRH ) antagonist protocol , single injection human chorionic gonadotropin ( hCG ) trigger final follicular maturation luteal phase support vaginal micronized progesterone . Single , fresh D3 D5 embryo transfer Key Frozenthawed embryo transfer More 20 oocyte current control ovarian hyperstimulation ( COH ) cycle Serum P4 great 1.5 ng/mL day hCG administration</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>IVF</keyword>
	<keyword>ICSI</keyword>
</DOC>